Apologies if info on this has been posted before I couldn't find anything post July 2019.
I know this isn't as topical as COVID-19 (selfish i know, I don't have COVID-19 but do have disc issues) has anyone seen any information coming out of the MSB sponsored Phase 3 trial:
Placebo-controlled Study to Evaluate Rexlemestrocel-L Alone or Combined With Hyaluronic Acid in Subjects With Chronic Low Back Pain (MSB-DR003)
which was mooted as having: Estimated Primary Completion Date :March 2020
How long after primary completion would we expect results to be published?
Apologies if info on this has been posted before I couldn't find...
-
- There are more pages in this discussion • 16,372 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
96.0¢ |
Change
0.025(2.67%) |
Mkt cap ! $1.096B | |||
| Open | High | Low | Value | Volume |
| 95.0¢ | 96.5¢ | 94.0¢ | $1.231M | 1.291M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 94461 | 95.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 96.0¢ | 61151 | 6 |
View Market Depth
| Last trade - 16.10pm 12/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |